Maternal, Embryofetal and Teratogenic Toxicity of Gel-Forming Galactomannan from Cassia grandis in Wistar Rats.
4 affiliations
- 1Department of Medicine, University of Pernambuco (UPE), Garanhuns Campus, Garanhuns 53.294-902, PE, Brazil.
- 2Laboratory of Farmatoxicological Prospecting of Bioactive Products (BIOFARMATOX), Department of Antibiotics, Federal University of Pernambuco (UFPE), Recife Campus, Recife 54.740-520, PE, Brazil.
- 3Department of Morphology and Animal Physiology, Animal Bioscience Program, Federal Rural University of Pernambuco (UFRPE), Recife Campus, Recife 52.171-900, PE, Brazil.
- 4Institute of Biological Sciences (ICB), University of Pernambuco (UPE), Recife Campus, Recife 50.100-130, PE, Brazil.
Abstract
This study aimed to evaluate the potential maternal and developmental toxicity of orally administered galactomannan extracted from Cassia grandis seeds during the pre-implantation and organogenesis periods in Wistar rats. Considering the promising biotechnological potential of this gel-forming polysaccharide, its safety evaluation during pregnancy is essential. In vitro analysis using the MTT assay demonstrated that galactomannan (1-10 µg/mL) was not cytotoxic to L929 fibroblasts. In vivo, pregnant rats treated with 0.1, 1.0, or 10 mg/kg showed no clinical signs of maternal toxicity, including alterations in behavior, body weight gain, or food or water intake. Additionally, no alterations were observed in the absolute or relative weights of maternal organs. During the pre-implantation phase, no differences were observed in the number of corpora lutea, implantation sites, or pre-implantation losses. Histological analyses of implantation sites and placentas revealed normal morphology in all groups. Exposure during organogenesis did not induce external, visceral, or skeletal malformations, and no significant changes were detected in reproductive parameters. A significant overall difference in fetal body weight was observed with a significant pairwise difference only between the 0.1 and 10 mg/kg groups; however, neither group differed significantly from the control. In conclusion, the oral administration of C. grandis galactomannan at the tested doses did not produce maternal, embryotoxic, or teratogenic effects in Wistar rats. However, further studies involving broader dose ranges, larger sample sizes, and formulation-specific assessments are necessary before conclusions regarding reproductive safety in biomedical applications can be established.
Related
- Teratogenic Effects and Outcomes of Congenital Oropouche Virus Infection: Current Evidence, Pathophysiological Mechanisms, and Research Priorities.
- Live immunogenic melanoma cells generated by etoposide treatment upregulate B2M and lose tumor-forming potential
- EBF1 controls an embryonic artery-forming niche that reactivates in pulmonary arterial hypertension
- Postoperative malnutrition predicts severe chemotherapy toxicity after gastrectomy: evaluation of an inflammation-anemia phenotype
- Extracorporeal photopheresis for cancer immunotherapy-related gastrointestinal toxicity: emerging clinical evidence.
BibTeX
@article{nunes2026maternal,
title = {{Maternal, Embryofetal and Teratogenic Toxicity of Gel-Forming Galactomannan from Cassia grandis in Wistar Rats.}},
author = {Daniel Medeiros Nunes and André Luís Salvino Alves de Oliveira and Alisson Rodrigo da Silva Oliveira and Anísio Francisco Soares and Teresinha Gonçalves da Silva and Luiza Rayanna Amorim de Lima and Natalie Emanuelle Ribeiro Rodrigues and Priscilla Barbosa Sales de Albuquerque},
journal = {Gels (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/gels12100936},
url = {https://europepmc.org/article/MED/42929970},
note = {CC BY},
}
RIS
TY - JOUR
TI - Maternal, Embryofetal and Teratogenic Toxicity of Gel-Forming Galactomannan from Cassia grandis in Wistar Rats.
AU - Daniel Medeiros Nunes
AU - André Luís Salvino Alves de Oliveira
AU - Alisson Rodrigo da Silva Oliveira
AU - Anísio Francisco Soares
AU - Teresinha Gonçalves da Silva
AU - Luiza Rayanna Amorim de Lima
AU - Natalie Emanuelle Ribeiro Rodrigues
AU - Priscilla Barbosa Sales de Albuquerque
PY - 2026
DA - 2026/10/18
JO - Gels (Basel, Switzerland)
DO - 10.3390/gels12100936
UR - https://europepmc.org/article/MED/42929970
AB - This study aimed to evaluate the potential maternal and developmental toxicity of orally administered galactomannan extracted from Cassia grandis seeds during the pre-implantation and organogenesis periods in Wistar rats. Considering the promising biotechnological potential of this gel-forming polysaccharide, its safety evaluation during pregnancy is essential. In vitro analysis using the MTT assay demonstrated that galactomannan (1-10 µg/mL) was not cytotoxic to L929 fibroblasts. In vivo, pregnant rats treated with 0.1, 1.0, or 10 mg/kg showed no clinical signs of maternal toxicity, including alterations in behavior, body weight gain, or food or water intake. Additionally, no alterations were observed in the absolute or relative weights of maternal organs. During the pre-implantation phase, no differences were observed in the number of corpora lutea, implantation sites, or pre-implantation losses. Histological analyses of implantation sites and placentas revealed normal morphology in all groups. Exposure during organogenesis did not induce external, visceral, or skeletal malformations, and no significant changes were detected in reproductive parameters. A significant overall difference in fetal body weight was observed with a significant pairwise difference only between the 0.1 and 10 mg/kg groups; however, neither group differed significantly from the control. In conclusion, the oral administration of C. grandis galactomannan at the tested doses did not produce maternal, embryotoxic, or teratogenic effects in Wistar rats. However, further studies involving broader dose ranges, larger sample sizes, and formulation-specific assessments are necessary before conclusions regarding reproductive safety in biomedical applications can be established.
SN - 2310-2861
ER -